Figure 4.
WBC profiles during chemotherapy with or without rhG-CSF. Model simulation (bold line) compared with clinical trial data (open circles connected by the thin line represent the median WBCs; the gray shaded area depicts the variability by the interquartile range). Dashed vertical lines indicate the start of each therapy cycle. Black triangles indicate the administration of rhG-CSF. The dashed horizontal line marks the normal WBC range.